BlackRock, Inc. 13D and 13G filings for CorMedix Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | CorMedix Inc. CRMD | BlackRock Inc. BLK | 3,507,695 6.400% | 2,869,917 (+449.99%) | Filing |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | CorMedix Inc. CRMD | BlackRock Inc. BLK | 637,778 1.600% | -1,862,943 (-74.50%) | Filing |
| 2022-02-02 7:18 pm Purchase | 2021-12-31 | 13G | CorMedix Inc. CRMD | BlackRock Inc. BLK | 2,500,721 6.600% | 505,528 (+25.34%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | CorMedix Inc. CRMD | BlackRock Inc. BLK | 1,995,193 6.200% | 282,292 (+16.48%) | Filing |
| 2020-02-07 08:45 am Purchase | 2019-12-31 | 13G | CorMedix Inc. CRMD | BlackRock Inc. BLK | 1,712,901 6.700% | 1,712,901 (New Position) | Filing |